1. Home
  2. BON vs BOLT Comparison

BON vs BOLT Comparison

Compare BON & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.32

Market Cap

10.6M

Sector

Health Care

ML Signal

N/A

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$4.62

Market Cap

10.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BON
BOLT
Founded
2006
2015
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.5M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BON
BOLT
Price
$1.32
$4.62
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$34.00
AVG Volume (30 Days)
20.5K
21.2K
Earning Date
01-23-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,695,000.00
Revenue This Year
$390.73
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$1.13
$3.91
52 Week High
$3.39
$7.20

Technical Indicators

Market Signals
Indicator
BON
BOLT
Relative Strength Index (RSI) 58.03 45.25
Support Level $1.32 $4.29
Resistance Level $1.33 $5.05
Average True Range (ATR) 0.06 0.34
MACD 0.01 -0.05
Stochastic Oscillator 59.89 22.86

Price Performance

Historical Comparison
BON
BOLT

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: